Botulinum Toxin for Improvement of Penis Health and Male Sexual Function
1.
Giuliano F, Joussain C, Denys P. Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport®) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction—Case Studies. Toxins. 2019;11(5):283. doi:10.3390/toxins11050283
2.
Abdelrahman IFS, Raheem AA, Elkhiat Y, Aburahma AA, Abdel-Raheem T, Ghanem H. Safety and efficacy of botulinum neurotoxin in the treatment of erectile dysfunction refractory to phosphodiesterase inhibitors: Results of a randomized controlled trial. Andrology. 2022;10(2):254-261. doi:10.1111/andr.13104
3.
El-Shaer W, Ghanem H, Diab T, Abo-Taleb A, Kandeel W. Intra-cavernous injection of BOTOX® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial. Andrology. 2021;9(4):1166-1175. doi:10.1111/andr.13010
4.
Emura F, Peura D. Interview with Barry J. Marshall. Winner of the Nobel Prize in Medicine for the Discovery of Helicobacter pylori. :8.
5.
Giuliano F, Denys P, Joussain C. Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series. Toxins. 2022;14(4):286. doi:10.3390/toxins14040286
6.
Habashy E, Köhler TS. Botox for Erectile Dysfunction. The Journal of Sexual Medicine. 2022;19(7):1061-1063. doi:10.1016/j.jsxm.2022.03.216
Find Nearest Priapus Toxin™ Procedure Provider
Safety of Botulinum Toxin
1.
Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Current Medical Research and Opinion. 2004;20(7):981-990. doi:10.1185/030079904125003962
2.
Stephens ML, Balls M. LD50 Testing of Botulinum Toxin for Use as a Cosmetic. 2005;(2):5.
3.
Bhatia KP, Munchau A, Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases. Journal of Neurology, Neurosurgery & Psychiatry. 1999;67(1):90-93. doi:10.1136/jnnp.67.1.90
4.
Frevert J. Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®. Drugs R D. 2010;10(2):67-73. doi:10.2165/11584780-000000000-00000
5.
Dhaked RK, Singh MK, Singh P, Gupta P. Botulinum toxin: Bioweapon & magic drug. Indian J Med Res. 2010;132(5):489-503. Accessed September 1, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028942/
6.
Omprakash HM, Rajendran SC. Botulinum Toxin Deaths: What is the Fact? J Cutan Aesthet Surg. 2008;1(2):95-97. doi:10.4103/0974-2077.44169
7.
Arnon SS, Schechter R, Inglesby TV, et al. Botulinum Toxin as a Biological WeaponMedical and Public Health Management. JAMA. 2001;285(8):1059-1070. doi:10.1001/jama.285.8.1059
8.
Nigam PK, Nigam A. BOTULINUM TOXIN. Indian J Dermatol. 2010;55(1):8-14. doi:10.4103/0019-5154.60343
9.
botulinum toxin 100 Units – Summary of Product Characteristics (SmPC) – (emc). Accessed September 1, 2022. https://www.medicines.org.uk/emc/product/859/smpc#gref